PartnershipMay 18, 2026, 04:07 PM
Evogene & Bayer Discontinue Herbicide Development Project
AI Summary
Evogene Ltd. announced that its subsidiary, Ag Plenus Ltd., and Bayer Ag have mutually agreed to discontinue their herbicide development project. The decision was made because the target protein did not meet the required product criteria. Effective May 18, 2026, all assets previously licensed to Bayer under the collaboration, including the APTH1 protein target and associated active molecules, will revert to Ag Plenus.
Key Highlights
- Evogene's subsidiary Ag Plenus and Bayer discontinued their herbicide development project.
- The decision was due to the target protein not meeting required product criteria.
- Termination of the collaboration is effective May 18, 2026.
- All licensed assets, including the APTH1 protein target, revert to Ag Plenus.
Price Impact
More from EVGN